PET: a revolution in medical imaging

被引：41

作者：

Alavi, A

Lakhani, P

Mavi, A

Kung, JW

Zhuang, HM

机构：

[1] Hosp Univ Penn, Dept Radiol, Div Nucl Med, Philadelphia, PA 19104 USA

[2] Albert Einstein Med Ctr, Philadelphia, PA 19141 USA

来源：

RADIOLOGIC CLINICS OF NORTH AMERICA | 2004年 / 42卷 / 06期

关键词：

D O I：

10.1016/j.rcl.2004.08.012

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

This article emphasizes the rapidly evolving role of fluorodeoxyglucose-PET (FDG-PET) imaging in the assessment of neoplastic diseases, infectious and inflammatory processes, and cardiovascular and central nervous system disorders. This article also discusses the development of new radiotracers that should further enhance and expand the role of PET imaging in the detection of hypoxia, cell proliferation, and movement disorders. The article briefly considers the potential role of other functional imaging techniques such as nuclear MR spectroscopy and optical imaging in assessing metabolism and function in certain settings. Finally, it addresses the necessity of precise structural/functional correlation in many settings and forecasts future trends for this major imaging modality.

引用

页码：983 / +

页数：20

共 190 条

[1]

ALAVI A, 1994, J NUCL MED, V35, P1650

[2]

Alavi A, 1998, J NUCL MED, V39, P1363

[3] POSITRON EMISSION TOMOGRAPHY IMAGING OF REGIONAL CEREBRAL GLUCOSE-METABOLISM [J].